1174496

Robert J. Hayashi, MD — FEI 3022205731

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 8, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Saint Louis, MO (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance